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abstract
Among the many uses of digital pathology, remote consultation, remote revision, and virtual slide panels may be
the most important ones. This requires basic slide scanner infrastructure in participating laboratories to produce
whole-slide images. More importantly, a software platform is needed for exchange of these images and
functionality to support the processes around discussing and reporting on these images without breaching
patient privacy. This poses high demands on the setup of such a platform, given the inherent complexity of the
handling of digital pathology images. In this article, we describe the setup and validation of the Pathology Image
Exchange project, which aimed to create a vendor-independent platform for exchange of whole-slide images
between Dutch pathology laboratories to facilitate efficient teleconsultation, telerevision, and virtual slide panels.
Pathology Image Exchange was released in April 2018 after technical validation, and a first successful validation
in real life has been performed for hematopathology cases.
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INTRODUCTION
Pathology is a broad medical specialty covering cell
and tissue diagnostics of all organs and body parts. In
view of the explosion of knowledge in medical science,
it has become impossible for the practicing pathologist
to keep up with the developments in all fields and
maintain sufficient diagnostic knowledge in every area.
Because erroneous diagnoses may lead to inadequate
treatment of patients, it is often necessary to consult
more specialized colleagues.1 Such specialists may
not always be at hand locally, especially in smaller
general practices, in which case a colleague in another
practice can be consulted.
Traditionally, such consultations take place by sending
slides throughmail back and forth. This is an expensive
and laborious logistic process that easily takes up to 2
weeks, depending on distances and adequacy of tra-
ditional mail logistics. In addition, it is also error prone;
slides may be broken during transportation or even get
lost completely. Patient reports can easily be taken from
broken or opened packages during transportation,
breaching patient privacy. Finally, during this process,
patients are eagerly awaiting the final report with their
diagnosis, treatments are delayed, and patient anxiety
levels are high, often causing patients to call in sick.
A similar process takes place when patients are re-
ferred to another hospital, in which case it is customary
to ship the pathology material to reassess (revise) the
patient’s situation because revision may take into
account new information on the patient and hence the
diagnosis may be adjusted or errors may be corrected.
It also serves to translate the report into local usual and
up-to-date language and ensures that material is
available for demonstration at multidisciplinary
meetings and for comparison with new material (eg,
biopsies from metastases). A further issue with
sending over glass slides is that the receiving de-
partment does not always send back all the slides
because they need to archive the reviewed slides.
Another logistical challenge involves pathology expert
panels, where pathologists discuss difficult and/or
interesting samples to reach consensus at a multi-
headed microscope, requiring many pathologists to
travel to a central laboratory with obvious loss of
productivity. For some specialized areas such as soft
tissue and bone pathology, mesothelial lesions, and
hematopathology, discussing patients at such panels
is even deemed mandatory. These panels usually take
place once a month, again causing much delay in
diagnosis and treatment.
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On the basis of a survey of Dutch academic laboratories,
the annual numbers of consultations, revisions, and panel
cases in the Netherlands are estimated at 10,000, 30,000,
and 6,000, respectively, in a population of 17 million
people. The previously discussed logistical issues call for
a more intelligent, quicker, safer, and cheaper solution,
which may be found in digital technology.2 The introduction
of fast and high-quality whole-slide scanners over the past
10 years has enabled practitioners to perform consulta-
tions, revisions, and pathology expert panels much quicker,
even on the same day, in a completely digital way by having
whole-slide images (WSIs) of the complete set of slides
available. However, WSIs are between 0.5 and 4 GB in size,
making exchange of these images a far from trivial chal-
lenge, and accompanying patient data cannot be freely
shared over the Internet.
In light of all these issues, the Dutch focus group on digital
pathology initiated the setup of a national platform for
exchange of WSIs between Dutch pathology departments
in 2013. The platform had to be scanner vendor in-
dependent, low threshold, and user-friendly, to allow for
faster consultation, revision, and slide panels. The platform
was developed and titled Pathology Image Exchange (PIE).
The plan was embraced by the boards of the Dutch Society
of Pathology (NVVP) and the Dutch Pathology National
Archive (PALGA), which appointed an implementation
group. Although many laboratories did not have scanning
equipment at the time, it was deemed the right moment to
avoid the situation where regional islands with incompatible
platforms would be established, which would hinder na-
tional exchange of WSI.
STAKEHOLDERS
Besides the NVVP and PALGA, the Netherlands Compre-
hensive Cancer Organization (IKNL) supported the PIE
initiative. PALGA has been responsible for collecting and
hosting all of the Dutch pathology reports since 1971, and
PALGA’s infrastructure, which covers and connects all
pathology laboratories in the Netherlands (n = 58), would
obviously play a central role in exchange of image-related
data in a safe way. As an independent quality and
knowledge institute, IKNL has an interest in faster con-
sultations, revisions, and slide panels to increase the quality
of diagnosis for patients with cancer and has sponsored
pathology expert panels (and earlier also consultations and
revisions) for many years.
Because PIE needs to be run professionally to guarantee
the requested 98% uptime, it was decided that PIE would
be best hosted under the responsibility of PALGA, which
has experience with the governance of the national data-
bases. For the purpose for running this project, a new
foundation run by the PALGA and NVVP councils, the
Stichting Pathologie Projecen, was created. The required
funds for setting up PIE were jointly generated by the NVVP,
IKNL, PALGA, all of the eight pathology departments of the
University Medical Centers (UMCs), and two nonacademic
hospitals; the PIE initiative was also funded through a
governmental quality improvement grant of the Stichting
Kwaliteitszorg Medische Specialismen.
PRINCIPLES OF PIE
During the preparation phase of the acquisition bymeans of
a European tender process, the following basic principles
were defined. First, it should initially support use cases,
including consultations, revisions, and expert panels.
Second, there should be low-threshold entry in terms of
subscription, technical implementation, and ease of use.
Third, all laboratories should in principle be able to con-
nect, independent of the local choices regarding, for ex-
ample, the laboratory information management system and
scanner vendor, while being able to continue using their
own viewer. Fourth, the platform should safeguard patient
privacy for identifiable patient information, and information
exchange should be secure. Finally, the solution should be
affordable and comply with regulations and applicable law.
To support these principles, the following technical prin-
ciples were formulated as well. First, all identifiable patient
information, including clinical context and process in-
formation, should be transmitted using the PALGA Lab2Lab
infrastructure that was developed specifically for secure
data transfer between the Dutch pathology laboratories
connected to PALGA. Second, there should be support and
use of international health care information technology (IT)
standards for interoperability whenever possible.3 This was
accomplished by mandating the support for integration
profiles as described by Integrating the Healthcare
Enterprise,4,5 such as Cross-Enterprise Document Sharing
for Imaging (XDS-i).6 In addition, the support for Digital
Imaging and Communications in Medicine (DICOM) Sup-
plements 122 and 1457 was mandatory, although we knew
that many vendors did not support this in the preparation
and tender phase. Third, for laboratories to be able to keep
using their own viewer, the platform should support the
ability to uploadWSIs to the central repository or to leave the
images at their decentral location and stream the images
from those facilities. Finally, it should be possible to con-
nect to existing health information exchanges.
THE EUROPEAN TENDER PROCESS
Because PALGA is a government-funded agency and the
expected price of the solution would exceed the threshold
for obligatory tenders, the PIE enactment required a Eu-
ropean tender (documents are available on request). To
professionally organize this, a consultant with specific ex-
pertise in digital pathology and medical data exchange was
hired (A.H.), as well as a consultant with expertise in setting
up and running European tenders (B. Epema, Mitopics,
Gouda, the Netherlands). In addition, an IT architect fa-
miliar with the PALGA IT infrastructure was hired (J.v.E.).
The process started with a Request for Information pro-
cedure to investigate the feasibility of the platform.
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Nineteen potential vendors responded and were positive
about the opportunities of the platform. With the input from
all coauthors plus some additional experts from the
aforementioned Focus Group Digital Pathology, the re-
quirements were defined and listed in a statement of re-
quirements. The requirements, the tender process, and the
maximum acceptable price were posted online in a trans-
parent process as required for European tenders. From
potential vendors, it was required to state compliance with
regard to the requirements. The selection phase involved
an interview with the project manager and the IT architect
as well as a demonstration. This, together with the price,
formed the input of a weighted calculation to select the
vendor. Five vendors responded to the tender request. The
contract was granted to a consortium of three companies—
Sectra (Linko¨ping, Sweden), RAM-IT (Utrecht, the Nether-
lands), and Deutsche Telekom Healthcare Solutions (Bunnik,
the Netherlands)—to build and implement the software
platform.
TECHNICAL REQUIREMENTS
The listed requirements were mainly based on a functional
description of the desired workflows for the mentioned use
cases and the principles mentioned earlier. With regard to
the expert panel functionality, the number of requirements
was limited, and the supplier had to come up with a detailed
development and implementation plan if an off-the-shelf
solution was not yet available. A reference architecture was
provided to clarify the responsibilities of the different parties
involved and how the connections between the different
systems were supposed to work (Fig 1). Vendors were
allowed to diverge from this reference architecture as long
as they complied with the defined principles and other
requirements. From a technical perspective, the
architecture was based on an XDS-i.b infrastructure as
defined by Integrating the Healthcare Enterprise,4 in-
cluding the following major actors:
1. Central registry or index: Basically, the central registry or
index can identify which cases with images are stored in
which repository or imaging document sources.
2. Central imaging document source or repository: In
this repository, images can be centrally stored after
uploading to avoid the hassle to connect all laboratories
to each other, enabling direct access to the images.
Technically, the imaging document sources or re-
positories can then be located anywhere (eg, in hospitals
or externally).
3. Imaging document consumer: This is the viewer part
of an XDS-i solution, centrally provided by PIE to display
the images as stored in the central repository. Techni-
cally, it is possible to use a locally installed consumer,
as long as it is compatible with the XDS-i integration
profile and has access to the location of the images and
is able to stream the Images over the internet (eg, using
WADO-RS).
In the PIE reference architecture, two differences from the
commonly used architecture for image exchange in radi-
ology were introduced. First, images are allowed to
be transmitted not only in DICOM format, but also in a
few other supported proprietary formats (Hamamatsu
Photonics [Hamamatsu, Japan], Aperio [Leica, Wetzlar,
Germany], 3DHistech [Budapest, Hungary], Zeiss [Ober-
kochen, Germany]) and common open formats such as
BigTiff. Second, the primary key for the patients is not
a case, patient, or unique citizen identifier (ie, in the
Netherlands, the burgerservicenummer) but a case key
that is transmitted together with the images and with the
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FIG 1. Conceptual architecture of Pathology Image Exchange (PIE), the Dutch national platform for exchange of whole-slide images between pathology
laboratories. Based on the IHE XDS-i integration profile. IMS, Imaga Management System (also referred to as PACS; Picture Archiving and Communications
System); kern U-DPS, integration component provided by the Dutch Pathology National Archive (PALGA) to laboratories to facilitate communication between
central facilities and other laboratories; LIS, Laboratory Information System.
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process metadata as transmitted through the PALGA
Lab2Lab module. In addition, the diagnosis is transmitted
over the PALGA network back to the requesting laboratory.
PROVIDED SOLUTION
The solution that was offered by the consortium initially
consisted of the following two models to actually make
images available to the central image repository: manual
upload through aWeb interface and automated upload with
a locally installed uploader tool. The first model needs little
installation or software integration; the Web page can be
easily accessed by a URL launch from the primary workflow
system the pathologist is using. The second model, tailored
for laboratories needing a higher volume, needs more in-
tegration but makes the process even more automatic,
requires fewer user actions, and is more patient safe. The
solution was compliant with the PIE requirements de-
scribed earlier. When the native support for XDS-i by PACS
(Picture Archiving and Communications System) solutions
in use at laboratories is implemented, it will be possible to
directly register patients with the central registry and avoid
the need to upload the images, which will be a third way to
make images available. Mobile device functionality is
available for the expert panel solution.
IMPLEMENTATION AND VALIDATION
Four laboratories were selected for pilot implementation
(Erasmus Medical Center, Rotterdam; LabPAL, Dordrecht;
University Medical Center Utrecht, Utrecht; and Radboud
University Medical Center, Nijmegen), and four expert
panels were selected (thymomas, soft tissue tumors, he-
matology, and Barret esophagus). For each upload
method, two laboratories were involved in the pilot, and
some additional laboratories were involved because of the
expert panel pilot projects. During the pilot phase, extensive
expert panel functionality was developed by DTHS. The
pilot projects started in February 2017 and were finished
by April 2018 after successful technical validation.
For real-life validation, 38 patient cases were digitally sent
by a senior UMC Utrecht resident through PIE for con-
sultation to Nijmegen in the summer of 2018 when the
UMCUtrecht consultant hematopathologists were on leave,
using automated upload functionality. These cases in-
cluded 22 bone marrow biopsies, eight lymph node bi-
opsies, four skin biopsies, and a single breast, colon, small
bowel, and brain biopsy each. The average number of
slides or images per patient was 15 (range, four to 44 slides
or images). The slides or images for 18 patients were
viewed in Nijmegen on the same day, 19 within 24 hours,
and one within 48 hours. A digital diagnosis on the existing
images could be made in 35 (92%) of 38 patients with
acceptable certainty (22 patients with high certainty and 13
patients with acceptable certainty), with only three patients
requiring additional attention. On glass slide revision by
a UMC Utrecht hematopathologist, the digital diagnoses
could be confirmed in all patients. Figure 2 provides some
screenshots of PIE.
DISCUSSION
Project PIE was initiated in 2013 to create a nationwide
platform for exchange of WSIs between the Dutch pa-
thology laboratories for low-threshold, user-friendly, and
faster consultations, revisions, and slide panels. The
platform provides the required viewer and workflow func-
tionality for digital consultations, revisions, and slide panels
on the basis of WSIs (Sectra); server hosting and storage
(RAM-IT); and safe connections and laboratory imple-
mentations (DTHS). At rollout in April 2018, it was the first
of its kind in the world.
Key to patient-safe exchange of WSIs and accompanying
patient data, as well as efficient transfer of consultation and
revision reports between laboratories, is the role of PALGA,
which developed the Lab2lab module for this purpose,
among other uses. PIE was technically successfully vali-
dated for both the automated and manual upload. For real-
life validation, a set of lymphoreticular biopsies (considered
to be difficult cases with, on average, 15 slides each) were
digitally consulted by automated upload between UMC
Utrecht and Nijmegen. All patient cases but one were
viewed within 24 hours, and a digital diagnosis on the
existing images was made in 35 (92%) of 38 patients with
acceptable certainty, with all diagnoses confirmed after-
ward on the glass slides. This demonstrates the potential of
PIE for speeding up the consultation process.
Although every laboratory is responsible for the local clinical
validation, use of the PIE platform will need to be further
validated for the various scanners and various types of
slides (eg, frozen sections, liquid-based cytology, im-
munofluorescence, immunohistochemistry) according to
a protocol based on the College of American Pathologists
guidelines8 (Table 1). This will take place in the near future,
and it is anticipated that this may require additional fine-
tuning of the software. The success of PIE will largely
depend on the willingness of Dutch pathology laboratories
to use scanner capacity to at least allow digital revision,
consultation, and pathology expert panel activities. Many
pathology departments currently have a scanner or are in
the process of acquiring scanning capacity. The PIE
roadshow that is being held has raised a lot of attention and
new ideas on functionality.
Much of the requested functionality is already available,
and because of the two different models to upload patient
cases, there is a low threshold to get started. However, PIE
still faces several challenges before all laboratories are
connected. First, the Dutch scanner landscape is diverse,
mainly consisting of Hamamatsu, Philips (Amsterdam, the
Netherlands), Leica (Aperio), and 3DHistech. The PIE
Sectra viewer already reads the file formats from Hama-
matsu, Leica (Aperio), and 3DHistech, and Zeiss and
BigTiff export from some other vendors, but to fully comply
van Diest et al
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with the required vendor neutrality, the viewer must support
DICOM WSI output according to the latest standard.7
Vendors are encouraged to use DICOM to make WSIs
available to the PIE platform, and most vendors are doing
this or are working on supporting this standard. PIE will
thereby probably boost the adaptation to the DICOM
standard.
Second, connections need to be created for all the different
laboratory information management systems and reporting
systems around the Netherlands to support the Lab2Lab
communication mechanism, such as LMS-POEMA (DTHS),
Tieto Sympathy (Tieto, Espoo, Finland), Sysmex Delphic
(Sysmex, Auckland, New Zealand), Uniform Decentraal
PALGA Systeem (PALGA, Houten, the Netherlands), and
MIPS GLIMS (MIPS, Gent, Belgium), in combination with
different PACS vendors. Third, the Lab2Lab communica-
tion module needs to be adapted to provide integration with
manual and automatic image upload to PIE for patient-safe
data transfer.
The PIE project was prefinanced by contributions from
Stichting Kwaliteitszorg Medische Specialismen, NVVP,
PALGA, and IKNL and by voluntary contributions from
several pathology laboratories including all the UMCs. The
model for the running costs still needs to be fine-tuned
because it is yet unclear how high these running costs will
be. Part of these costs are covered by IKNL as an in-
vestment in innovation of expertise development in pa-
thology. To cover the remaining running costs, several
options are available. The laboratories that get connected
to PIE will need to pay for this connection (and for the
Lab2Lab connectivity) via a fixed fee (based on the di-
agnostic volume of the laboratory) or a pay-per-view
approach. The first option creates the low-threshold
environment that we want to achieve and enables pre-
dictable revenues for PIE, but could easily lead to massive
overuse of the platform, so a fair-use policy may then have
to be defined. In addition, a fixed fee may make the de-
cision for laboratories to get connected to PIE more difficult
and could lead to a low initial number of connected lab-
oratories. The second option, the pay-per-view approach,
will make consultation more high threshold and will make
the revenue generated by PIE much less predictable but
would be cheaper for laboratories that do not use the
system often and could lead to many laboratories quickly
deciding to get connected to PIE. For now, a model with
three fixed fees depending on the expected number of PIE
transactions is being explored.
FIG 2. Screenshot of the Pathology Image Exchange (PIE) viewer.
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It is not easy to estimate the potential savings from the use
of PIE. The 40,000 consultation, revision, and panel cases
form the potential market for PIE after full rollout in the
Netherlands. With approximately 40 fully functional pa-
thology laboratories, this is approximately 1,000 cases on
average per laboratory, meaning 2,000 shipments per
laboratory because cases are sent back and forth. Mail
charges alone would be about V5 each, so approximately
V10,000 per laboratory. Rough estimates of personnel
costs are about half a secretary per laboratory, which is
another V15,000 per laboratory. The total average costs
per laboratory for the mail circus is thereby estimated at
approximately V25,000.
As to lessons learned, it was complicated to define spec-
ifications for the expert panels because of varying insights
of consulted panel members and because not all had
extensive experience working digitally. Therefore, this part
of the tender was underspecified, which made imple-
mentation harder. In addition, the prerequisite of having
Lab2Lab with the associated additional costs (although
Lab2Lab is needed not only for PIE but also for other
interlab communication) turned out to be a hurdle for
laboratories willing to participate. It would have been better
if Lab2Lab had been implemented before rollout of PIE.
PIE in its current form may be a stepping stone for a wider
use of digital technology in, for example, multidisciplinary
meetings or even digital diagnostics in regional or nation-
wide networks.9,10 For now, PIE will need to first conquer its
place within the Dutch pathology community, but func-
tionality is expected to be expanded by improvements such
as a live voice discussion module, interactive viewing with
more than two users, integrated speech recognition, image
analysis/deep learning algorithms, and use of private
viewers when WADO-RS is implemented. Upscaling to the
international level is also a realistic option. On the horizon,
the platform has the potential to make artificial intelligence
algorithms available to all pathology departments in
a vendor-neutral fashion, allowing for thorough validation
and harmonization. Finally, as a spin-off, its potential in
research on pathology image sets is immense.
Hopefully, other countries will initiate similar projects,
where specific hurdles will need to be overcome, especially
with regard to safe transfer of patient data. This is not
impossible; for example, in the United Kingdom, there is
a similar network for radiology (The Sectra Image Exchange
Portal),11 and other (eg, regional) health information ex-
change networks have resolved this by only exchanging
patient information over secure connections on the basis of
explicit patient consent.
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